James Kimmel, Jr., is a lecturer of psychiatry at the Yale School of Medicine, a lawyer, and the founder and co-director of the Yale Collaborative for Motive Control Studies. He is the creator of The ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

A popular class of drugs for treating diabetes and obesity reduces addiction, including abuse of alcohol, tobacco, cannabis, ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Live from WYFF 4 studios, Chronicle: State of Addiction was a community event that featured law enforcement and addiction specialists answering viewer questions and discussing issues and solutions ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for ...

First-person stories of drug addiction, hope, healing, and recovery. Addiction is a complex and often misunderstood condition. This gripping special provides raw, unfiltered access to first-person ...

Drugs originally designed to treat diabetes and obesity are reshaping medicine in unforeseen ways. Their impact on public health is really unprecedented in modern times, perhaps only upstaged by ...

What’s driving the permanent crisis of drug addiction? To express the ambient feeling that “things are getting worse,” there exists, of course, a meme. It plots iterations of a chart, and on its ...